文献速递神经核医学

[18F]F13640:一种用于人体功能性5-HT1A受体显像的选择性激动剂PET放射性药物

[18F]F13640: a selective agonist PET radiopharmaceutical for imaging functional 5-HT1A receptors in humans.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2023-01-19

本研究在13名健康男性志愿者中开展PET/CT与PET-MRI扫描,评估选择性5-HT1A受体激动剂[18F]F13640的脑内标记特征并建立简化定量模型。结果显示中缝核与皮层区域高摄取,LREF模型在重测信度与可靠性方面表现更优,小脑白质与额叶白质可作为参考区域。

要点

  • [18F]F13640在人体脑内中缝核与皮层区域呈高摄取。
  • LREF模型与采用动脉输入函数的动力学模型高度相关,重测信度与可靠性更优。
  • 小脑白质与额叶白质可作为[18F]F13640的合适参考区域。

核心结论

  • [18F]F13640具有良好的脑内标记与动力学特征、高受体特异性及高效激动剂特性,为研究功能性活跃的5-HT1A受体提供新视角。
  • 其动力学特性允许在PET扫描仪外注射并延迟采集,便于在神经病学与精神病学中设计创新的纵向研究方案。

研究设计与样本

  • 在13名健康男性志愿者(29±9岁)中开展PET/CT与PET-MRI扫描,其中9名行动脉输入函数(AIF)测定,8名进行重测方案。
  • 比较了单组织隔室模型、双组织隔室模型与Logan模型,并评估了简化参考组织模型(SRTM)与Logan参考模型(LREF)。

主要发现

  • [18F]F13640在中缝核与皮层区域显示高摄取值。
  • SRTM与LREF模型与采用AIF的动力学模型呈很高相关性。
  • 就重测参数与[18F]F13640延长的结合动力学而言,LREF方法的重测信度与可靠性更优。
  • 小脑白质与额叶白质可作为合适的参考区域。

关键数值与推荐

  • SRTM与LREF模型与采用AIF的动力学模型呈很高相关性。
  • LREF方法在重测信度与可靠性方面优于其他方法。
  • 小脑白质与额叶白质被确定为合适参考区域。

临床怎么用

  • [18F]F13640的动力学特性允许在PET扫描仪外注射并延迟采集,便于设计神经病学与精神病学的纵向研究方案。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: F13640 (a.k.a. befiradol, NLX-112) is a highly selective 5-HT1A receptor ligand that was selected as a PET radiopharmaceutical-candidate based on animal studies. Due to its high efficacy agonist properties, [18F]F13640 binds preferentially to functional 5-HT1A receptors, which are coupled to intracellular G-proteins. Here, we characterize brain labeling of 5-HT1A receptors by [18F]F13640 in humans and describe a simplified model for its quantification. METHODS: PET/CT and PET-MRI scans were conducted in a total of 13 healthy male volunteers (29 ± 9 years old), with arterial input functions (AIF) (n = 9) and test-retest protocol (n = 8). Several kinetic models were compared (one tissue compartment model, two-tissue compartment model, and Logan); two models with reference region were also evaluated: simplified reference tissue model (SRTM) and the logan reference model (LREF). RESULTS: [18F]F13640 showed high uptake values in raphe nuclei and cortical regions. SRTM and LREF models showed a very high correlation with kinetic models using AIF. As concerns test-retest parameters and the prolonged binding kinetics of [18F]F13640, better reproducibility, and reliability were found with the LREF method. Cerebellum white matter and frontal lobe white matter stand out as suitable reference regions. CONCLUSION: The favorable brain labeling and kinetic profile of [18F]F13640, its high receptor specificity and its high efficacy agonist properties open new perspectives for studying functionally active 5-HT1A receptors, unlike previous radiopharmaceuticals that act as antagonists. [18F]F13640's kinetic properties allow injection outside of the PET scanner with delayed acquisitions, facilitating the design of innovative longitudinal protocols in neurology and psychiatry. TRIAL REGISTRATION: Trial Registration EudraCT 2017-002,722-21.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Courault P, Lancelot S, Costes N, et al. [18F]F13640: a selective agonist PET radiopharmaceutical for imaging functional 5-HT1A receptors in humans. Eur J Nucl Med Mol Imaging. 2023. PMID: 36656363. doi:10.1007/s00259-022-06103-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。